Appili Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of March 2025: 0.00x

Appili Therapeutics Inc cash flow reinvestment rate. Appili Therapeutics Inc (APLI) has a Cash Flow Reinvestment Rate of 0.00x as of March 2025, reinvesting CA$2.36K (capex CA$2.36K ) from operating cash flow of CA$1.03 Million. Explore how well can Appili Therapeutics Inc service its debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

CA$2.36K

Capex + Investments

Operating Cash Flow

CA$1.03 Million

CAD

Capital Expenditures

CA$2.36K

CAD

Cash Flow Reinvestment Rate of Appili Therapeutics Inc (2025–2025)

Cash flow reinvestment rate of Appili Therapeutics Inc from 2025 to 2025. Historical reinvestment intensity for Appili Therapeutics Inc across 1 annual periods. Explore reinvestment intensity of Appili Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.

Appili Therapeutics Inc Cash Flow Reinvestment Rate by Year (2025–2025)

Appili Therapeutics Inc cash flow reinvestment rate by year from 2025 to 2025. Year-by-year capital reinvestment analysis for Appili Therapeutics Inc. For the full cash flow conversion analysis, see APLI cash generation efficiency.

Year	Reinvestment Rate	Total Reinvested (CAD)	Operating CF	Capex	YoY Change
2025	0.01x	CA$4.72K	CA$868.82K	CA$2.36K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow